普通外文研报
Managed Care: The 3 most likely scenarios for Q2, Hint: most are bullish
研报英文原文证据摘录
Managed Care: The 3 most likely scenarios for Q2, Hint: most are bullish
Exhibit 2: Stocks mentioned
Prices and ratings for stocks mentioned in this report
BofA Ticker Bloomberg ticker Company name Price Rating
CNC CNC US Centene Corporation US$ 59.55 C-1-9
ELV ELV US Elevance Health Inc US$ 391.27 B-1-7
HUM HUM US Humana Inc US$ 327.54 C-2-7
UNH UNH US UnitedHealth Grp US$ 377 C-1-7
Source: BofA Global Research
BofA GLOBAL RESEARCH
Price objective basis & risk
Centene Corporation (CNC)
Our $74 price objective is based on a 16.4x multiple on our 2027E EPS estimate, above
the 5 year average (11.5x). We see this as justified due to the acceleration we expect in
EPS growth as Medicaid margins normalize in medium term with states increasing rates
to better reflect recent changes in trend and risk pools. Exchanges could be volatile but
early data is positive and CNC can reprice issues in 2027+ giving us comfort that
earnings power than can be restored in the next few years.
Upside risks to our price objective are trend deceleration, Medicaid enrollment
stabilization, and faster than expected Medicaid rate increases from states.
Downside risks to our price objective are continued negative risk pool shifts, state
Medicaid budgets tightening, further acceleration in enrollment declines, exchange risk
pool degradation.
Elevance Health Inc (ELV)
Our $460 PO is based on 15.7x our 2027E EPS, above the 5YR average of 13.4x,
reflecting the acceleration in EPS growth as Medicaid and Exchanges normalize from
trough margins. We see rates improving from states as rates start to reflect recent
trend/risk pool data.
Risks to the downside are trend is higher than expected, a more competitive pricing
environment, it will take longer for states to catch up on new acuity levels in Medicaid,
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器